Choose one to see options and pricing.
Provider-Prescribed GLP-1 Therapy
Complete a health assessment for review by a licensed healthcare provider. Treatment is available only when prescribed following an appropriate medical evaluation.
Choose 12 months for $1,044 ($87/month), 6 months for $767 (about $128/month), 3 months for $447 (about $149/month), or month-to-month for $189. Plans renew at the length you choose; cancel anytime.
Prescription treatment requires evaluation and approval by a licensed healthcare provider. Eligibility is not guaranteed. Individual treatment plans and outcomes vary. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality before marketing. Pricing and program terms are subject to applicable eligibility and fulfillment requirements.
Which option may be right for you?
GLP-1 receptor agonist
May help reduce appetite
Supports blood-sugar regulation
May support gradual weight reduction
Typically the more cost-conscious option
GLP-1 + GIP receptor agonist
May help reduce appetite and food cravings
Supports blood-sugar regulation
Acts on two hormone pathways
Individual results and side effects vary
Provider-guided care, delivered to your door
GET STARTED →Prescription required. A licensed provider determines whether treatment is medically appropriate. Completing an assessment does not guarantee a prescription. Individual results vary.
If prescribed, treatment may include a compounded medication. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. VevaRx is not a pharmacy. Medication is dispensed by a licensed pharmacy when prescribed.
Clear answers, personalized care, and support for your next step.
Start your assessmentTirzepatide is a once-weekly injectable medication that acts on two hormone pathways, GLP-1 and GIP. These hormones help regulate appetite, fullness and blood sugar, which is why tirzepatide is used in medical weight management.
Tirzepatide is the active ingredient in FDA-approved brand-name medications. If a VevaRx provider prescribes tirzepatide for you, it is a compounded formulation prepared by a licensed pharmacy. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before marketing.
VevaRx pricing is all-inclusive: your provider evaluation, medication if prescribed, supplies and shipping are part of one plan price. No insurance is needed.
Plans renew at the length you choose, and you can cancel anytime.
Tirzepatide is generally considered for adults who want medical support with weight management, often alongside changes to diet and activity. Your provider makes the final decision based on your full health history.
Tirzepatide may not be appropriate if you:
The most commonly reported side effects of tirzepatide are digestive: nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and stomach discomfort. They are often most noticeable when starting or increasing a dose.
Less common but serious risks include pancreatitis, gallbladder problems, low blood sugar (especially with other diabetes medications) and kidney problems related to dehydration. Contact your provider if you have side effects, and seek emergency care for severe stomach pain or signs of an allergic reaction.
Plans start at $189 month-to-month, or as low as about $87 per month on a 12-month plan ($1,044). Each plan includes your provider evaluation, medication if prescribed, supplies and free shipping.
No. Tirzepatide is the active ingredient in FDA-approved brand-name medications, but compounded versions are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness or quality before marketing. Compounded medications are prepared by licensed pharmacies when prescribed by a licensed provider.
Semaglutide acts on one hormone pathway (GLP-1). Tirzepatide acts on two (GLP-1 and GIP). Both are once-weekly injections used in medical weight management. Your provider can help you decide which is more appropriate for you. Learn about semaglutide.
Tirzepatide is a once-weekly injection given under the skin. Your provider will give you instructions specific to your treatment plan.
No. VevaRx is a self-pay program. Your plan price covers the provider visit, medication if prescribed, supplies and shipping.
If you are approved, your medication typically ships in 2 to 3 days in discreet packaging at no extra cost.
No. A licensed provider reviews your assessment and decides whether treatment is medically appropriate. If you are not a candidate, you will not be prescribed tirzepatide.
Yes. Plans renew at the length you choose, and you can cancel anytime.
This information is educational and is not a substitute for medical advice. Prescription treatment requires evaluation and approval by a licensed healthcare provider. Individual results vary. VevaRx is not a pharmacy; medication is dispensed by a licensed pharmacy when prescribed.
Answer a few quick questions to discover which provider-guided plan may fit your goals.
By submitting, you agree to receive wellness updates from VevaRX. We respect your privacy and will never share your information.
